Agilent’s competitive advantage stems from its established position in life-science instrumentation. It is recognized as a “global leader” in analytical and diagnostic lab tools. Its brand and broad product portfolio (instruments, software, services) create intangible value.
Customers often face high switching costs because Agilent’s equipment and service contracts become integral to lab workflows. The CrossLab segment (service and consumables) further ties clients in. However, the scientific instruments market has other strong players (Thermo Fisher, Waters, Shimadzu, etc.), so Agilent’s moat is moderate.
We see a single-moat business: good but not indestructible, earning a mid-range score (~60).







